Alzchem Group AG
Alexander Dippold began their work experience in 2010 at Ludwig-Maximilians-Universität München, where they worked on their promotion until September 2013. In 2014, they joined Alzchem Group AG as a Lab Manager until October 2016. Alexander then moved on to become a Product Manager for Multi Purpose Plants, specializing in Fine chemicals, Intermediates, and Custom Manufacturing, starting in November 2016. Currently, they hold the position of Head of Business Management Custom Manufacturing at Alzchem Group AG, starting in January 2023.
Alexander Dippold pursued their education in chemistry and biochemistry at Ludwig-Maximilians-Universität München. Alexander received their Bachelor of Science (BS) degree in 2008 after completing their studies spanning from 2005 to 2008. Alexander then continued their academic endeavors by pursuing a Master of Science (MS) degree in chemistry, which they successfully completed between 2008 and 2010.
This person is not in any teams
This person is not in any offices
Alzchem Group AG
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem benefits from the three very different global developments climate change, population growth and longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting social goals in a multitude of different applications. The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are the company's response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,630 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of around EUR 422.3 million and EBITDA of around EUR 62.0 million in 2021.